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The aims of this study were to assess the effect of a homeopathic 
agent (Mercúrios Corrosivos 6 CH) and a non-steroidal anti-
inflammatory drug (nimesulide) on the progression of the alveolar 
bone loss in experimentally induced periodontitis in rats. Sixty (60) 
Wistar rats were divided into group 1 (homeopathy), group 2 
(nimesulide) and group 3 (saline solution). Silk ligatures were placed 
at the gingival margin level of the lower right first molar of all rats.  
Alveolar bone loss was evaluated and analyzed using software Image 
J. The results were submitted to the analysis of variance (ANOVA) 
and Tukey’s posttest (p<0.05). The analysis revealed that there was a 
higher bone loss in diseased sites as compared with healthy sites. A 
significant reduction in the alveolar bone resorption was observed in 
group 2 (nimesulide) as compared with groups 1 (homeopathy) and 3 
(control), 7 days after the induction of periodontal disease. Our data 
provided evidence that homeopathy does not decrease alveolar bone 
loss as opposed to nimesulide in experimentally induced periodontitis. 
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Inflammatory periodontal disease represents the most 
important cause of tooth loss in adults (ARMITAGE, 1999; 
KANTARCI; VAN DYKE, 2005; HORTZ; CONRADS, 2007). Although 
multifactorial, the pathogenesis of periodontitis involves the presence 
of a plaque factor that initiates local inflammatory reaction in a 
predisposed host, thus provoking edema, cell influx, and release of 
inflammatory mediators. This pathogenesis consists of a cascade of 
inflammatory and immunological reactions, which have not yet been 
fully elucidated (CURTIS, 2005; KANTARCI; VAN DYKE, 2005; 
HORTZ; CONRADS, 2007). 
Several studies have demonstrated that cyclooxygenase-2 
(COX-2) is involved in the pathogenesis of periodontitis 
(OFFENBACHER; HEASMAN; COLLINS, 1993; LOHINAI et al., 
2001). In pathophysiological states, such as in inflammatory reactions, 
triggering of this inducible isoenzyme, induces the production of great 
amounts of prostaglandins, like prostaglandins E2, which are 
important mediators in causing tissue destruction and alveolar bone 
loss in periodontal disease (WILLIANS et al., 1985; JOUZEAU et al., 
1997; BEZERRA et al., 2000). Therefore, it has been suggested that 
therapeutic benefits resulting from classical non-steroidal anti-
inflammatory drugs (NSAIDs) use are derived from a COX-2 
blockade, whereas a concomitant cyclooxygenase-1 (COX-1) 
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For the dentist who attempt to practice as a physician of the 
mouth with preventive dental medicine as a part of his/her service, 
clinical experience has demonstrated that homeopathy can be of 
benefit. Many homeopathic remedies have been found to be effective 
for dental conditions, namely dental caries, dental abscess, oral 
lesions, post-extraction bleeding and even medications to treat the 
anxious and nervous child (BELLAVITE et al., 2005; BELLAVITE et 
al., 2006a, 2006b, 2006c; BELLAVITE et al., 2007; BELLAVITE; 
ORTOLANI; CONFORTI, 2006). The evidence demonstrates that in 
some conditions homeopathy shows significant promise, e.g. 
Galphimia glauca (low dilutions/potencies) in allergic oculorhinitis, 
classical individualized homeopathy in otitis and possibly in asthma 
and allergic complaints, and a few low-potency homeopathic 
complexes in sinusitis and rhinoconjunctivitis. A general weakness of 
evidence derives from lack of independent confirmation of reported 
trials and from presence of conflicting results, as in case of 
homeopathic immunotherapy and of classical homeopathy for upper 
respiratory tract infection (BELLAVITE et al., 2005; BELLAVITE et al., 
2006a, 2006b, 2006c; BELLAVITE et al., 2007; BELLAVITE; 
ORTOLONI; CONFORTI, 2006).  
There has been growing public demand for the application of 
alternative or complementary medicine to some diseases (VAN 
WASSENHOVEN, 2005; CAULFIELD; DEBOW, 2005; MAXION-
BERGEMANN et al., 2006; HAIDVOGL et al., 2007; SCHNEIDER et 
al., 2008). Conventional scientific wisdom dictates that homeopathy 
should have no effect above placebo but experiments on ultra-high 
dilutions of solutes together with some clinical data suggest the 
intriguing possibility that it might do in some circumstances 
(BELLAVITE et al., 2006a, 2006b, 2006c; BELLAVITE; ORTOLANI; 
CONFORTI, 2006). However, the mechanisms of action of these 
drugs are far from clear, and no previous research aimed at showing 
the effect of homeopathic treatment on alveolar bone loss in rats.  
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Therefore, the aim of this study was to compare and evaluate 
whether homeopathy and nimesulide, a preferential COX-2 inhibitor, 
alter alveolar bone loss during the progression of experimentally 
induced periodontitis in rats. 
 
Materials and Methods 
 
Animals and induction of periodontal disease 
 
The Institutional Experimentation Committee for Animal 
Experiments approved the protocol for this study (protocol # 01/2006). 
Sixty (60) male Wistar rats weighing 300 g were separated into group 
1 (Homeopathy - Mercúrios Corrosivos 6 CH (dilution: etílico alcohol 
30%) – for 3 consecutive days, 2 drops  every 8 h; 4th – 10th day, 2 
drops  every 4 h; 11th – 30th day, 2 drops every 2h; n=20), group 2 
(Nimesulide, 2.83 mg/kg, every 12h, Novaquímica Sigma Pharma 
Natures Plus, Hortolândia/SP, Brazil; n=20) and group 3 (Control; 0.1 
mL of 0.9% saline solution every 12 h; n=20). The experimental 
periodontitis model in rats was described previously (OLIVEIRA et al., 
2008; RODINI et al., 2008). The rats were anesthetized with Tiopental 
(Thiopentax®, 60 mg/kg – intraperitoneally) and received surgically a 
silk thread ligature around the lower right first molar in a submarginal 
position to induce experimental periodontitis. The animals were 
euthanized after 3 and 7 days by excess of anesthetic.  The animals 
were housed in temperature-controlled rooms and received water and 
food ad libitum. 
 
Measurement of Alveolar Bone Loss 
 
The left and right maxillary were stained with aqueous 
methylene blue (1%) in order to differentiate bone from teeth by an 
examiner previously trained and calibrated. Bone loss was analyzed 
using software Image J (The National Institutes of Health – NIH) to 
measure the distance between the cusp tip and alveolar bone crest. In 
these conditions, the alveolar bone landmark was determined by 
methylene blue staining that clearly determines the cemento-enamel 
junction to the alveolar bone crest. The measurements were made 
along the long axis of the vestibular root surfaces of all molar teeth. 
Total alveolar bone loss was obtained by measurements expressed in 




The statistical significance was assessed by ANOVA, 
followed by multiple comparisons with Tukey’s test. A statistically 




A clinical macroscopic analysis of the right and left 
mandibular first molars was performed for each animal, verifying the 
presence of alveolar bone loss and consequent tooth mobility (Fig 1, 
upper panel).  
The analysis of alveolar bone loss revealed that there was a 
statistically significant difference in diseased sites as compared with 
healthy sites (left side without ligature) in all groups and periods 
studied.  A statistically lower level (p<0.05) of alveolar bone loss was 
observed in group 2 (nimesulide) as compared with groups 1 
(homeopathy) (p= 0,0094)  and 3 (control) (p=  0,0376)  , 7 days after 
the induction of periodontal disease (Fig 1, lower panel). 
Double measurements of the alveolar bone loss of 30 
specimens were performed within the period of two week by a single, 
calibrated, blind examiner. A correlation was obtained between the 2 

















                    
 
 
Figure 1 – Illustrative effect of homeopathy, nimesulide and saline solution on the alveolar bone loss in experimentally-induced periodontal 
disease in rats (upper panel) as well as values expressed as mean ± standard error of mean (lower panel). * indicates statistically significant 








There is evidence that animals treated with various anti-
inflammatory drugs show less periodontal destruction (WILLIANS et 
al., 1985; BEZERRA et al., 2000; MORTON et al., 2001; BEZERRA et 
al., 2002; ALENCAR et al., 2002; LEITÃO et al., 2004; BHAT; 
SARGOD; GEORGE, 2005; OLIVEIRA et al., 2008). Rats have been 
extensively used to study the effects of these drugs in the 
periodontium.  In the present study, the rat model of periodontitis, 
which comprises a ligature around the tooth, was utilized 
(OFFENBACHER; HEASMAN; COLLINS, 1993; JOUZEAU et al., 
1997; KHUDA-BUKHSH, 2003; BHAT; SARGOD; GEORGE, 2005; 
RODINI et al., 2008; OLIVEIRA et al., 2008). This model is 
characterized by accumulation of biofilm, flattening and displacement 
of the gingival crest, increasing of the number of bacteria on the 
dentogingival area and alveolar bone loss (OFFENBACHER; 
HEASMAN; COLLINS, 1993). Thus, it may be considered an 
acceptable model for the study of periodontal disease. 
In the present study, we studied the effect of a homeopathic 
agent (Mercúrios Corrosivos 6 CH) and a non-steroidal anti-
inflammatory drug (nimesulide) on the alveolar bone loss progression 
in experimentally induced periodontitis in rats.  Non-steroidal anti-
inflammatory drugs can be given for pain, but these drugs are not 
always tolerated. There is an increasing trend among physicians and 
dentists in many countries, towards the use of complementary and 
alternative medicine (CAM) in addition to, and in some cases instead 
of conventional medicine (JONAS ; KAPTCHUK; LINDE, 2003; 
SCHNEIDER et al., 2008).  Growing popularity of CAM in the public 
sector is reflected in the scientific community by an increased number 
of research articles assessing its therapeutic effects. Homeopathy is 
one of the most widespread and most controversial forms of CAM 
(CAULFIELD; DEBOW, 2005; WITT et al., 2005; KEIL et al., 2008). 
Results suggest lower costs for CAM than for conventional patients, 
but the limited methodological quality lowers the significance of the 
available data. Further well-designed studies and models are required 
(WITT et al., 2005; MAXION-BERGEMANN et al., 2006; KEIL et al., 
2008).  
This study revealed that the groups treated with nimesulide 
and homeopathy showed significant difference at 7 days after the 
induction of periodontal disease. The administration of nimesulide 
prevented the onset of significant bone loss at 7 days after induction 
of periodontal disease when compared with homeopathy and control.  
Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) that 
preferentially inhibits COX-2, and is not only a potent inhibitor of acute 
exudation but also an intense inhibitor of bone destruction. Other 
works confirmed that the COX-2 preferential inhibitors can be effective 
in preventing alveolar bone loss in experimental periodontitis in rats 
(JOUZEAU et al., 1997; MORTON et al., 2001; BEZERRA et al., 
2002; ALENCAR et al., 2002; OLIVEIRA et al., 2008). 
Based on the findings of the present study and due to the 
current lack of evidence-based homeopathic treatment for periodontal 
diseases, the homeopathy cannot considered a possible effective 
alternative for periodontitis. The current situation is that few and rather 
small groups are working on laboratory models for homeopathy. 
Regarding the interpretation of data in view of the simile principle, we 
observe that there are different levels of similarity and that the 
laboratory data give support to this principle, but have not yet yielded 
the ultimate answer to the action mechanism of homeopathy. 
Evidence of the biological activity in vitro of highly diluted-dynamized 
solutions is slowly accumulating, with some conflicting reports 
(BELLAVITE et al., 2005; BELLAVITE et al., 2006a, 2006b, 2006c; 
BELLAVITE et al., 2007; BELLAVITE; ORTOLONI; CONFORTI, 
2006). While clinical effects of some homeopathic drugs could be 
convincingly shown, one of the greatest objections to this modality lies 
in its inability to explain the mechanism of action of the microdoses 
based on scientific experimentations and proofs.  
Though many aspects of the mechanism of action still 
remain unclear, serious efforts have now been made to understand 
the molecular mechanisms of biological responses to the potentized 
form of homeopathic drugs (JONAS; KAPTCHUK; LINDE, 2003; 
SCHNEIDER et al., 2005; BELLAVITE et al., 2005; BELLAVITE et al., 
2006a, 2006b, 2006c; BELLAVITE et al., 2007; BELLAVITE; 
ORTOLONI; CONFORTI, 2006; SCHNEIDER et al., 2008). Many 
other questions should be prioritized, such as the potential of 
homeopathy to avoid invasive procedures and the long-term effects of 
homeopathy in preventing chronic complications (VAN 
WASSENHOVEN et al., 2005; OBERBAUM et al., 2005). Further 
studies should be performed to explore the various aspects that are 




Our data provided evidence that the systemic therapy with 
COX-2 preferential inhibitors can modify the progression of 
periodontitis by decreasing alveolar bone loss and that homeopathy 
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